Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer

  • Dmitriy I Dovzhanskiy1,
  • Stefanie M Arnold1,
  • Thilo Hackert1,
  • Ina Oehme2,
  • Olaf Witt2, 3,
  • Klaus Felix1,
  • Nathalia Giese1 and
  • Jens Werner1Email author
BMC Cancer201212:226

DOI: 10.1186/1471-2407-12-226

Received: 10 January 2012

Accepted: 8 June 2012

Published: 8 June 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
10 Jan 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
14 Feb 2012 Reviewed Reviewer Report - Naomi Walsh
19 Feb 2012 Reviewed Reviewer Report - Ling Peng
20 Apr 2012 Author responded Author comments - Dmitriy Dovzhanskiy
Resubmission - Version 3
20 Apr 2012 Submitted Manuscript version 3
3 May 2012 Reviewed Reviewer Report - Naomi Walsh
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
8 Jun 2012 Editorially accepted
8 Jun 2012 Article published 10.1186/1471-2407-12-226

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of General Surgery, University of Heidelberg
(2)
German Cancer Research Center (DKFZ)
(3)
Department of Pediatric Oncology, University of Heidelberg Medical Center

Advertisement